Arcellx (ACLX) Accumulated Expenses (2021 - 2025)
Arcellx's quarterly Accumulated Expenses came in at $35.1 million in Q4 2025, down 38.15% year-on-year from $56.7 million in Q4 2024, and up 233.04% quarter-over-quarter from $10.5 million in Q3 2025.
Arcellx has reported Accumulated Expenses for 5 years, with the latest figure at $35.1 million in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Expenses fell 38.15% year-over-year to $35.1 million; the trailing twelve-month figure through Dec 2025 stood at $35.1 million (down 38.15% YoY), and the FY2025 full-year result was $35.1 million, down 38.15% from the prior year.
- Accumulated Expenses for Q4 2025 stood at $35.1 million, up from $10.5 million in the prior quarter.
- The five-year high for Accumulated Expenses was $56.7 million in Q4 2024, with the low at $793000.0 in Q1 2022.
- Average Accumulated Expenses over 5 years is $17.1 million, with a median of $11.7 million recorded in 2022.
- Year-over-year, Accumulated Expenses soared 1665.07% in 2023 and sank 82.29% in 2024.
- Tracing ACLX's Accumulated Expenses over 5 years: stood at $1.3 million in 2021, then jumped by 797.69% to $11.7 million in 2022, then jumped by 56.71% to $18.3 million in 2023, then soared by 209.89% to $56.7 million in 2024, then slumped by 38.15% to $35.1 million in 2025.
- The last three Accumulated Expenses figures came in at $35.1 million (Q4 2025), $10.5 million (Q3 2025), and $53.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.08 Mn |
| Sep 30, 2025 | 10.53 Mn |
| Jun 30, 2025 | 53.03 Mn |
| Mar 31, 2025 | 3.14 Mn |
| Dec 31, 2024 | 56.72 Mn |
| Sep 30, 2024 | 43.04 Mn |
| Jun 30, 2024 | 5.16 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Dec 31, 2023 | 18.30 Mn |
| Sep 30, 2023 | 16.92 Mn |
| Jun 30, 2023 | 2.65 Mn |
| Mar 31, 2023 | 14.00 Mn |
| Dec 31, 2022 | 11.68 Mn |
| Sep 30, 2022 | 2.86 Mn |
| Jun 30, 2022 | 13.73 Mn |
| Mar 31, 2022 | 793,000.00 |
| Dec 31, 2021 | 1.30 Mn |